Fetal safety of erythromycin. An update of Swedish data.

Bengt Källén, Bengt R Danielsson

Research output: Contribution to journalArticlepeer-review

18 Citations (SciVal)


In previous studies from the Swedish Medical Birth Register, a possible association between erythromycin therapy and an increased risk for cardiovascular defects was found. Other studies using different methodology have not verified this observation. The finding resulted in a warning for the use of erythromycin in early pregnancy, followed by a marked decline in such use. The present study was conducted to follow up on the previous observations and to find methodological explanations for the variation in results in these different published studies.
Original languageEnglish
Pages (from-to)355-360
JournalEuropean Journal of Clinical Pharmacology
Issue number3
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Obstetrics, Gynecology and Reproductive Medicine


Dive into the research topics of 'Fetal safety of erythromycin. An update of Swedish data.'. Together they form a unique fingerprint.

Cite this